Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Fall Risk and Medication Use Near End of Life Among Adults With Chronic Obstructive Pulmonary Disease
Cara L McDermott1,2, Laura C Feemster3,4, Ruth A Engelberg3
1Division of Geriatrics and Palliative Care, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States.
Medications increasing fall risk are common in chronic obstructive pulmonary disease (COPD) patients. Reducing these fall-risk increasing drugs (FRIDs) may improve safety and prevent injurious falls in this population.
Area of Science:
- Gerontology
- Pharmacology
- Pulmonology
Background:
- Falls are a significant concern for individuals with chronic obstructive pulmonary disease (COPD).
- These falls lead to increased illness, death, and healthcare expenses.
- Identifying medication-related risk factors is crucial for fall prevention in COPD patients.
Purpose of the Study:
- To investigate the association between fall-risk increasing drug (FRID) burden and injurious falls in patients with COPD.
- To understand the prevalence of FRID use and specific drug classes associated with falls in this population.
Main Methods:
- Retrospective cohort study using electronic health records and death certificates (2014-2018).
- Included adults aged 40+ with COPD.
- Identified demographics, comorbidities, FRID burden, and injurious falls using ICD codes within two years prior to death.
Main Results:
- 30% of 8204 COPD decedents experienced an injurious fall within two years of death.
- 65% of patients used FRIDs; higher use of anticonvulsants, antipsychotics, and antidepressants was observed in patients with falls.
- FRID burden was significantly associated with increased odds of injurious falls (OR 1.07, 95% CI 1.04-1.09).
Conclusions:
- An opportunity exists for collaborative interventions between healthcare professionals and patients.
- Deprescribing and optimizing FRID use in COPD patients can enhance safety.
- This study underscores the importance of medication management in fall prevention for COPD patients.
More Related Videos
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction